144 related articles for article (PubMed ID: 3109547)
21. Cardiac safety of ophthalmic timolol.
Mäenpää J; Pelkonen O
Expert Opin Drug Saf; 2016 Nov; 15(11):1549-1561. PubMed ID: 27534869
[TBL] [Abstract][Full Text] [Related]
22. [Long-term treatment of chronic glaucoma with timolol drops: results after four years (author's transl)].
Plane C; Boulmier A
J Fr Ophtalmol; 1981; 4(11):751-6. PubMed ID: 7328270
[TBL] [Abstract][Full Text] [Related]
23. A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.
Denis P; Andrew R; Wells D; Friren B
Eur J Ophthalmol; 2006; 16(3):407-15. PubMed ID: 16761242
[TBL] [Abstract][Full Text] [Related]
24. [Beta-blocking treatment (author's transl)].
Scharrer A; Ober M
Klin Monbl Augenheilkd; 1981 Nov; 179(5):362-3. PubMed ID: 6121929
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients.
Renieri G; Führer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
J Ocul Pharmacol Ther; 2010 Dec; 26(6):597-603. PubMed ID: 20977366
[TBL] [Abstract][Full Text] [Related]
26. Bradycardia and congestive heart failure associated with ocular timolol maleate.
Linkewich JA; Herling IM
Am J Hosp Pharm; 1981 May; 38(5):699-701. PubMed ID: 7282702
[TBL] [Abstract][Full Text] [Related]
27. Modern alchemy: fixed combinations of glaucoma drugs.
Katz LJ
Am J Ophthalmol; 2005 Jul; 140(1):125-6. PubMed ID: 16038653
[No Abstract] [Full Text] [Related]
28. Third degree AC block due to ophthalmic timilol solution.
Sharifi M; Koch JM; Steele RJ; Adler D; Pompili VJ; Sopko J
Int J Cardiol; 2001; 80(2-3):257-9. PubMed ID: 11676388
[No Abstract] [Full Text] [Related]
29. [Asthma and beta-blocker eye drops (timolol, metipranolol, carteolol). Inhibition of chronotropic effects of isoprenaline].
Le Jeunne C; Munera Y; Teillet L; Hugues FC
Allerg Immunol (Paris); 1988 Sep; 20(7):267-9. PubMed ID: 2902862
[TBL] [Abstract][Full Text] [Related]
30. [Infrequent systemic drug interaction: repeated syncope caused by combined treatment with timolol-containing eye drops and lercanidipine tablet].
Kun E; Dienes L; Simonyi G; Finta E
Orv Hetil; 2019 Feb; 160(8):309-313. PubMed ID: 30773033
[TBL] [Abstract][Full Text] [Related]
31. Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination.
Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
J Ocul Pharmacol Ther; 2011 Dec; 27(6):581-7. PubMed ID: 22011049
[TBL] [Abstract][Full Text] [Related]
32. Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
Kendall K; Mundorf T; Nardin G; Zimmerman TJ; Hesse R; Lavin P
Clin Ther; 1987; 9(6):651-5. PubMed ID: 2894245
[TBL] [Abstract][Full Text] [Related]
33. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
[TBL] [Abstract][Full Text] [Related]
34. Severe bradycardia and syncope due to topical ophthalmic timolol.
Canpolat U; Gürses KM; Aytemir K; Oto A
Herz; 2013 Aug; 38(5):556-7. PubMed ID: 23338956
[No Abstract] [Full Text] [Related]
35. Fixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.
Higginbotham EJ; Olander KW; Kim EE; Grunden JW; Kwok KK; Tressler CS;
Arch Ophthalmol; 2010 Feb; 128(2):165-72. PubMed ID: 20142538
[TBL] [Abstract][Full Text] [Related]
36. Alopecia Induced by Timolol Eye-drops.
Muramatsu K; Nomura T; Shiiya C; Nishiura K; Tsukinaga I
Acta Derm Venereol; 2017 Feb; 97(2):295-296. PubMed ID: 27545615
[No Abstract] [Full Text] [Related]
37. Allergic contact conjunctivitis due to timolol in eyedrops.
Cameli N; Vicenzi C; Tosti A
Contact Dermatitis; 1991 Aug; 25(2):129-30. PubMed ID: 1935044
[No Abstract] [Full Text] [Related]
38. Allergic contact dermatitis from carteolol and timolol in eyedrops.
Quiralte J; Florido F; de San Pedro BS
Contact Dermatitis; 2000 Apr; 42(4):245. PubMed ID: 10750865
[No Abstract] [Full Text] [Related]
39. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
[TBL] [Abstract][Full Text] [Related]
40. Topical brimonidine 0.2%/timolol 0.5% ophthalmic solution: in glaucoma and ocular hypertension.
Frampton JE
Drugs Aging; 2006; 23(9):753-61. PubMed ID: 17020399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
